Stephen Robinson

Stephen Robinson is a seasoned pharmaceutical development professional with extensive experience in leadership roles across multiple organizations. Currently serving as Pharmaceutical Development Director at Drugs for Neglected Diseases initiative (DNDi) since 2019, Stephen previously held the position of Head of Pharmaceutical Development at DNDi from 2012 to 2018. Prior to joining DNDi, Stephen spent nearly two decades at Pfizer Global R&D in various capacities including Head of Transition Management and Senior Director of Research Portfolio Management, where responsibilities included strategic planning and oversight of global project portfolios. Stephen's earlier career includes roles at Lipha Pharmaceuticals and Unilever Research. Academic credentials encompass an MBA from the University of Kent, a Ph.D. in Physical Organic Chemistry from The Open University, and a B.Sc. in Chemical Sciences from the University of Leicester.